Canadian Online Pharmacy

CDER New June 5, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 4, 2013


New and Generic Drug Approvals

June 3, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Candesartan Cilexetil and Hydrochlorothiazide candesartan cilexetil; hydrochlorothiazide Tablet; Oral Apotex Inc Approval
Candesartan Cilexetil and Hydrochlorothiazide candesartan cilexetil; hydrochlorothiazide Tablet; Oral Dr Reddys Labs Ltd Approval
Embeda morphine sulfate; naltrexone hydrochloride Capsule, Extended Release; Oral Alpharma King Approval
Erivedge vismodegib Capsule; Oral Genentech Manufacturing Change or Addition
Fiorinal aspirin; butalbital; caffeine Capsule; Oral Watson Labs Inc Manufacturing Change or Addition
Fiorinal aspirin; butalbital; caffeine Tablet; Oral Watson Labs Inc Manufacturing Change or Addition
Halflytely bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride For Solution, Tablet, Delayed Release; Oral Braintree Manufacturing Change or Addition
Halflytely bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride Tablet, Delayed Release, For Solution; Oral Braintree Manufacturing Change or Addition
Hydroxyzine Pamoate hydroxyzine pamoate Capsule; Oral Emcure Pharms Usa Approval
Kalydeco ivacaftor Tablet; Oral Vertex Pharms Manufacturing Change or Addition
Nordette-28 ethinyl estradiol; levonorgestrel Tablet; Oral-28 Teva Branded Pharm Approval
Oxecta oxycodone hydrochloride Tablet; Oral King Pharms R and D Labeling Revision
Testosterone Cypionate testosterone cypionate Injectable; Injection Sun Pharm Inds Ltd Approval
Tracleer bosentan Tablet; Oral Actelion Pharms Ltd Manufacturing Change or Addition
Vpriv velaglucerase alfa Injectable; Iv (Infusion) Shire Human Genetic Manufacturing Change or Addition
Vpriv velaglucerase alfa Powder; Iv (Infusion) Shire Human Genetic Manufacturing Change or Addition
Zoledronic Acid zoledronic acid Injectable; Iv (Infusion) Hikma Farmaceutica Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery